Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,098 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $685.04 | 46 | $0 (2024) |
| PFIZER INC. | $260.47 | 14 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $244.86 | 4 | $0 (2021) |
| Esperion Therapeutics, Inc. | $166.20 | 4 | $0 (2021) |
| Amgen Inc. | $156.77 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $115.34 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $78.43 | 6 | $0 (2022) |
| Novo Nordisk Inc | $77.11 | 6 | $0 (2022) |
| Lilly USA, LLC | $44.50 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $41.91 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.75 | 14 | ABBVIE INC. ($170.53) |
| 2023 | $144.81 | 8 | ABBVIE INC. ($65.30) |
| 2022 | $385.19 | 27 | ABBVIE INC. ($151.29) |
| 2021 | $1,307 | 64 | AbbVie Inc. ($297.92) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.39 | General |
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $43.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Gastroenterology | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiology | ||||||
| 03/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Oncology | ||||||
| 08/28/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/22/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: VACCINES | ||||||
| 07/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 03/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: VACCINES | ||||||
| 10/31/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardio-renal | ||||||
| 08/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 66 | 291 | $52,095 | $12,035 |
| 2022 | 3 | 176 | 365 | $64,483 | $14,694 |
| 2021 | 5 | 400 | 881 | $146,126 | $44,315 |
| 2020 | 11 | 674 | 1,329 | $123,342 | $60,880 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 276 | $48,300 | $11,155 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,795 | $880.10 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 327 | $57,225 | $12,804 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $5,566 | $1,362 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 16 | $1,693 | $528.13 | 31.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 211 | 595 | $88,136 | $27,709 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 191 | $47,739 | $13,091 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,260 | $2,120 | 40.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 33 | 41 | $3,835 | $1,107 | 28.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 34 | $1,156 | $287.04 | 24.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 279 | 608 | $69,920 | $31,519 | 45.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 250 | 568 | $41,561 | $23,617 | 56.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 29 | 29 | $1,595 | $1,595 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 16 | 16 | $3,200 | $1,460 | 45.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 13 | $2,184 | $966.81 | 44.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $2,040 | $686.68 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 21 | $525.00 | $328.02 | 62.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 11 | $715.00 | $316.99 | 44.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 21 | $714.00 | $143.46 | 20.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 13 | $468.00 | $138.42 | 29.6% |
| 90471 | Administration of 1 vaccine | Office | 2020 | 14 | 14 | $420.00 | $108.72 | 25.9% |
About Rebecca Ohanian-Samarin, APRN
Rebecca Ohanian-Samarin, APRN is a Family Medicine healthcare provider based in Brandenburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1699197939.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rebecca Ohanian-Samarin, APRN has received a total of $2,098 in payments from pharmaceutical and medical device companies, with $261.75 received in 2024. These payments were reported across 113 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,098).
As a Medicare-enrolled provider, Ohanian-Samarin has provided services to 1,316 Medicare beneficiaries, totaling 2,866 services with total Medicare billing of $131,924. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family
- Location Brandenburg, KY
- Active Since 01/06/2014
- Last Updated 04/28/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699197939
Products in Payments
- UBRELVY (Drug) $294.49
- VRAYLAR (Drug) $285.37
- NURTEC ODT (Drug) $258.53
- COLOGUARD DNA CAPTURE REAGENTS (Device) $166.46
- NEXLIZET (Drug) $125.00
- QULIPTA (Drug) $105.18
- Aimovig (Biological) $102.77
- FARXIGA (Drug) $100.95
- TRELEGY ELLIPTA (Drug) $78.43
- ELIQUIS (Drug) $50.53
- EMGALITY (Drug) $44.50
- NEXLETOL (Drug) $41.20
- Cologuard Collection Kit (Device) $40.33
- Ozempic (Drug) $38.34
- Qutenza (Drug) $36.68
- EVENITY (Biological) $35.20
- MYRBETRIQ (Drug) $33.66
- Kerendia (Drug) $33.57
- JANUVIA (Drug) $29.51
- COMIRNATY (Biological) $29.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brandenburg
Dr. Bryan Honaker, M.d, M.D
Family Medicine — Payments: $8,965
Dr. Kyle King, M.d, M.D
Family Medicine — Payments: $8,725
Jeanetta Bosley, Md, MD
Family Medicine — Payments: $1,678
Dr. Robert Smith, M.d, M.D
Family Medicine — Payments: $1,289
Mrs. Teri Pierce, Arnp, ARNP
Family Medicine — Payments: $145.91
Dr. Raymond Mathis, D.o, D.O
Family Medicine